Fast Heartburn Relief Without Deadly Drugs
Since gastroesophageal reflux disease (GERD) was first identified in the early 1930s, the number of people experiencing heartburn has increased substantially.
In fact, one study shows that in just 10 years, the number of people experiencing:1
Any GERD symptoms increased by 30%
Symptoms at least once a week increased by 47%
Severe GERD increased by 24%
While these numbers are concerning, I’ll admit they’re not surprising considering the typical American diet.
Our nutrition-less, grain-based diet of carbohydrates and starches has wrecked our health and made our bodies behave in ways nature never intended.
This has led ...
Source: Al Sears, MD Natural Remedies - August 28, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Heart Health Natural Cures Nutrition Source Type: news
Marksans Pharma gets final USFDA nod for generic version of Famotidine tablets
Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Famotidine tablets indicated for the treatment of acid indigestion and heartburn. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 10, 2023 Category: Pharmaceuticals Source Type: news
Heartburn Drug Shows Promise Against COVID-19 Heartburn Drug Shows Promise Against COVID-19
In adults with mild to moderate COVID-19, treatment with a high-dose of famotidine led to early resolution of symptoms and inflammation in a randomized placebo-controlled trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 17, 2022 Category: Gastroenterology Tags: Infectious Diseases News Source Type: news
Zantac 360 (Famotidine) - updated on RxList
Zantac 360 (famotidine) is used to treat acid reflux disease, or GERD. Learn side effects, dosage, drug interactions, warnings, patient labeling, reviews, and more. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 28, 2021 Category: Drugs & Pharmacology Source Type: news
Can a heartburn drug help doctors treat COVID-19?
In the early days of the COVID-19 pandemic, doctors in Wuhan noticed something surprising. Many of the elderly patients who survived the virus were poor: not exactly the demographic you would expect to fare well in a health crisis.
A review of the survivors’ medical records revealed that a significant number suffered from chronic heartburn and were taking an inexpensive drug called famotidine, the key ingredient in Pepcid. (Source: World Pharma News)
Source: World Pharma News - August 20, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Alkem Laboratories launches Ibuprofen, Famotidine tablets in US market
Drug firm Alkem Laboratories on Wednesday announced the launch of Ibuprofen and Famotidine tablets, used to relieve the symptoms of rheumatoid arthritis and osteoarthritis, in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 4, 2021 Category: Pharmaceuticals Source Type: news
Zantac 360 (famotidine)
Title: Zantac 360 (famotidine)Category: MedicationsCreated: 5/12/2021 12:00:00 AMLast Editorial Review: 5/12/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 12, 2021 Category: Nutrition Source Type: news
Duexis (ibuprofen and famotidine)
Title: Duexis (ibuprofen and famotidine)Category: MedicationsCreated: 5/7/2021 12:00:00 AMLast Editorial Review: 5/7/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 7, 2021 Category: Rheumatology Source Type: news
Zantac (Famotidine) - updated on RxList
Zantac (famotidine) is used to treat acid reflux disease, or GERD. Learn side effects, dosage, drug interactions, warnings, patient labeling, reviews, and more. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 5, 2021 Category: Drugs & Pharmacology Source Type: news
Famotidine Has Uncertain Impact on COVID-19 Mortality Famotidine Has Uncertain Impact on COVID-19 Mortality
Famotidine use within 24 hours of admission does not improve but may worsen 30-day mortality of patients hospitalized with COVID-19, according to a retrospective study.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 30, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Donald Trump receiving Covid-19 treatment yet to be peer-reviewed
President ’s doctor reveals treatment with experimental antibody cocktail REGN-COV2Coronavirus – latest updatesSee all our coronavirus coverageDonald Trump is being treated with an experimental antibody drug that has shown promising initial early results but has yet to be peer-reviewed. According to statement from his doctor, the president has received a single eight-gram dose of anantibody cocktail called REGN-COV2– a combination of two human neutralising antibodies against the virus.The treatment was developed by Regeneron Pharmaceuticals, which previously developed a similar antibody drug against Ebola. He is also...
Source: Guardian Unlimited Science - October 2, 2020 Category: Science Authors: Melissa Davey, Ian Sample and agencies Tags: Donald Trump Coronavirus outbreak US news Infectious diseases Microbiology Medical research Science Source Type: news
Antihistamines May Help Calm COVID-19 Cytokine Storm Antihistamines May Help Calm COVID-19 Cytokine Storm
Dual histamine-receptor blockade with cetirizine and famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19, according to a new study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 11, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Another Trial Finds Famotidine Aids Hospitalized COVID Patients Another Trial Finds Famotidine Aids Hospitalized COVID Patients
An observational study of 83 hospitalized patients found that famotidine helped reduce in-hospital mortality and intubation. It also demonstrated lower levels of serum markers for severe disease.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 25, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Study claims patients taking Pepcid AC are more likely to survive COVID-19
Hartford Hospital in Connecticut has found that famotidine might help patients avoid mechanical ventilation and even improve the odds that they survive coronavirus - but the drug is controversial. (Source: the Mail online | Health)
Source: the Mail online | Health - August 19, 2020 Category: Consumer Health News Source Type: news
Popular Heartburn Drugs Linked to Heightened COVID-19 Risk
A popular form of heartburn medication may increase a person’s risk of developing COVID-19, according to a new study, lengthening the already long list of risk factors for the virus.
In the study, published Tuesday in pre-print form in the American Journal of Gastroenterology, scientists led by Cedars-Sinai Medical Center’s Dr. Brennan Spiegel conducted an online survey involving more than 86,000 people. Among them, more than 53,000 reported abdominal pain or discomfort, acid reflux, heartburn or regurgitation, and answered questions about the medications they took to relieve those symptoms. Of those, more than...
Source: TIME: Health - July 7, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
